Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2012
11/08/2012WO2012151541A1 Csf-1r inhibitors for treatment of brain tumors
11/08/2012WO2012151525A1 Novel compounds as modulators of protein kinases
11/08/2012WO2012151523A1 Csf-1r inhibitors for treatment of brain tumors
11/08/2012WO2012151512A2 Bromodomain inhibitors and uses thereof
11/08/2012WO2012151420A1 2α-METHYL AND 2β-METHYL ANALOGS OF 19,26-DINOR-1α, 25-DIHYDROXYVITAMIN D3 AND THEIR USES
11/08/2012WO2012151413A1 Methods for treating prostate cancer
11/08/2012WO2012151326A1 Method of treating cancer and bone cancer pain
11/08/2012WO2012151319A1 Cathepsin inhibitors for the treatment of bone cancer and bone cancer pain
11/08/2012WO2012151317A1 Vascular disruption agents and uses thereof
11/08/2012WO2012151266A1 Methods for handling biological drugs containing living cells
11/08/2012WO2012151141A2 A facile preparation of 4-substituted quinazolines and related heterocycles
11/08/2012WO2012151058A1 (20s)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin d3 analogs and their uses
11/08/2012WO2012150973A1 Compositions for regulating iron homeostasis and methods of using same
11/08/2012WO2012150952A1 Novel compounds and compositions for the inhibition of nampt
11/08/2012WO2012150869A1 Antibodies that bind trefoil factors and methods of using same
11/08/2012WO2012150683A1 Method for utilizing extraction residue of yeast extract
11/08/2012WO2012150663A1 Improved sugar-coated liposome composition
11/08/2012WO2012150543A1 Macrocyclic lactones and use thereof
11/08/2012WO2012150234A1 Dihydroquinoline derivatives as bromodomain inhibitors
11/08/2012WO2012150220A1 Radiolabeled amino acids for diagnostic imaging
11/08/2012WO2012150042A1 Compounds and methods for the identification of histone demethylase interacting molecules and for the purification of histone demethylase proteins
11/08/2012WO2012149667A1 Cardenolide compounds and antitumor use thereof
11/08/2012WO2012149653A1 Modulation of the sonic hedgehog pathway and uses thereof
11/08/2012WO2012149608A1 Prenylated hydroxystilbenes
11/08/2012WO2012149602A1 Multiple myeloma treatment
11/08/2012WO2012149601A1 Avian-based treatment
11/08/2012WO2012125828A3 Methods of treating breast cancer with anthracycline therapy
11/08/2012WO2012125405A9 Methods and materials for assessing responsiveness to lenalidomide, thalidomide, and/or other thalidomide analogs
11/08/2012WO2012122865A3 Pharmaceutically acceptable salt of (e)-n-[4-[[3-chloro-4-(2-pyridylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolyl]-3-[(2r)-1-methylpyrrolidin-2-yl]prop-2-enamide, preparation method therefor, and medical use thereof
11/08/2012WO2012119989A3 Antibodies against cadmi for the diagnosis and treatment of cancer
11/08/2012WO2012118813A3 Anti-il-6 receptor antibodies and methods of use
11/08/2012WO2012118812A3 Substituted 6,5-fused bicyclic heteroaryl compounds
11/08/2012WO2012092569A3 Compositions comprising immunostimulatory nucleic acids and related methods
11/08/2012WO2012083112A3 C- 17 -heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21
11/08/2012WO2012074960A3 Fty720-derived anticancer agents
11/08/2012WO2012068096A3 Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
11/08/2012WO2012033987A3 Anti-human folate receptor beta antibodies and methods of use
11/08/2012US20120283620 Treatment utilizing hydrophobic weak bases chemotherapeutic agents and illumination
11/08/2012US20120283328 Photosensitizer composition for treating skin disorders
11/08/2012US20120283318 Replicating viral vectors for gene therapy
11/08/2012US20120283313 Inhibition and treatment of prostate cancer metastasis
11/08/2012US20120283312 Modulation of eif4e expression
11/08/2012US20120283310 MicroRNA Signatures Associated with Human Chronic Lymphocytic Leukemia (CLL) and Uses Thereof
11/08/2012US20120283304 Formulations of Temozolomide for Parenteral Administration
11/08/2012US20120283302 Scca-1 production inhibitor having a carboxamide derivative and/or a salt thereof as an active ingredient
11/08/2012US20120283300 Use of benzo-heterocycle derivatives for preventing and treating cancer or for inhibiting cancer metastasis
11/08/2012US20120283299 Biguanide Derivative, A Preparation Method Thereof And A Pharmaceutical Composition Containing The Biguanide Derivative As An Active Ingredient
11/08/2012US20120283297 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
11/08/2012US20120283292 Fatty acid lenalidomide and their uses
11/08/2012US20120283288 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
11/08/2012US20120283287 Certain chemical entities, compositions, and methods
11/08/2012US20120283285 Treatment of solid tumors with rapamycin derivatives
11/08/2012US20120283284 Melonine bisindole compounds, pharmaceutical compositions, preparation method and use thereof
11/08/2012US20120283282 Photoproducts of Tryptophan, Their Synthesis and Uses Thereof
11/08/2012US20120283281 New (poly)aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents
11/08/2012US20120283280 Imidazotetrazinone-based combi-molecules
11/08/2012US20120283279 Combination
11/08/2012US20120283278 Combination
11/08/2012US20120283277 Inhibitors of bruton's tyrosine kinase
11/08/2012US20120283276 Inhibitors of bruton's tyrosine kinase
11/08/2012US20120283268 Thiazole and Thiophene Analogues, and Their Use in Treating Autoimmune Diseases and Cancers
11/08/2012US20120283266 Lysine specific demethylase-1 inhibitors and their use
11/08/2012US20120283262 Pharmaceutical compositions comprising sigma receptor ligands
11/08/2012US20120283261 Substituted n-phenylpyrimidin-2-amine analogs as inhibitors of the axl kinase
11/08/2012US20120283258 Mediators of hedgehog signaling pathways, compositions and uses related hereto
11/08/2012US20120283255 Urea derivatives, methods for their manufacture, and uses therefor
11/08/2012US20120283242 Di - substituted pyridine derivatives as anticancers
11/08/2012US20120283241 Imidazopyridazinecarbonitriles useful as kinase inhibitors
11/08/2012US20120283238 Irak inhibitors and uses thereof
11/08/2012US20120283236 Porphyrin Catalysts and Methods of Use Thereof
11/08/2012US20120283228 2alpha-Methyl and 2beta-Methyl Analogs of 19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 and Their Uses
11/08/2012US20120283227 (20S)-24-(p-Toluenesulfonyloxy)-25,26,27-Trinorvitamin D3 Analogs and Their Uses
11/08/2012US20120283220 Antofine and cryptopleurine derivatives as anticancer agents
11/08/2012US20120283215 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same
11/08/2012US20120283214 Cyclodextrin-based polymers for therapeutics delivery
11/08/2012US20120283206 Combination comprising N--4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent.
11/08/2012US20120283201 9-substituted minocycline compounds
11/08/2012US20120283198 Halogenated dideoxy sugar derivates, preparation method and application thereof
11/08/2012US20120283197 Compositions Comprising a Glucose Anti-Metabolite, BHA, and/or BHT
11/08/2012US20120283194 Inhibitors of Atypical Protein Kinase C and Their Use in Treating Hedgehog Pathway-Dependent Cancers
11/08/2012US20120283189 Na-k pump modulation
11/08/2012US20120283188 Genes and proteins associated with angiogenesis and uses thereof
11/08/2012US20120283187 Controlled release composition and method of producing the same
11/08/2012US20120283184 Inhibitors of type 2 vascular endothelial growth factor receptors
11/08/2012US20120283182 Peptide Modulators of the deltaPKC Interaction with the d Subunit of F1F0 ATP Synthase/ATPase and Uses Thereof
11/08/2012US20120283168 Template-fixed peptidomimetics with ccr10 antagonistic activity
11/08/2012US20120283166 Peptide prodrugs
11/08/2012US20120282622 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
11/08/2012US20120282464 Spherical Protein Particles and Methods of Making and Using Them
11/08/2012US20120282353 Methods, compositions and articles of manufacture for hif modulating compounds
11/08/2012US20120282342 Method for preparing polysaccharide nanocomposite particles and uses of the same
11/08/2012US20120282341 Lipid Formulated Compositions And Methods For Inhibiting Expression Of Eg5 And VEGF Genes
11/08/2012US20120282331 Mammalian metabolites of steroids
11/08/2012US20120282329 MUC1 Based Glycolipopeptide Vaccine with Adjuvant
11/08/2012US20120282327 Phosphate-containing nanoparticle delivery vehicle
11/08/2012US20120282325 Liposome of irinotecan or its hydrochloride and preparation method thereof
11/08/2012US20120282322 Cochleate compositions directed against expression of proteins
11/08/2012US20120282306 Polymer-agent conjugates, particles, compositions, and related methods of use
11/08/2012US20120282299 Coatings comprising bis-(alpha-amino-diol-diester) containing polyesteramide
11/08/2012US20120282286 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
1 ... 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 ... 2211